Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

144 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Targeted therapies in bladder cancer: an overview of in vivo research.
van Kessel KE, Zuiverloon TC, Alberts AR, Boormans JL, Zwarthoff EC. van Kessel KE, et al. Among authors: boormans jl. Nat Rev Urol. 2015 Dec;12(12):681-94. doi: 10.1038/nrurol.2015.231. Epub 2015 Sep 22. Nat Rev Urol. 2015. PMID: 26390971 Review.
RNA-based urinary assays for non-muscle invasive bladder cancer.
Pijpers OM, de Jong JJ, Zuiverloon TCM, Boormans JL. Pijpers OM, et al. Among authors: boormans jl. Curr Opin Urol. 2022 Sep 1;32(5):523-530. doi: 10.1097/MOU.0000000000001018. Curr Opin Urol. 2022. PMID: 35916010 Review.
Non-muscle-invasive bladder cancer molecular subtypes predict differential response to intravesical Bacillus Calmette-Guérin.
de Jong FC, Laajala TD, Hoedemaeker RF, Jordan KR, van der Made ACJ, Boevé ER, van der Schoot DKE, Nieuwkamer B, Janssen EAM, Mahmoudi T, Boormans JL, Theodorescu D, Costello JC, Zuiverloon TCM. de Jong FC, et al. Among authors: boormans jl. Sci Transl Med. 2023 May 24;15(697):eabn4118. doi: 10.1126/scitranslmed.abn4118. Epub 2023 May 24. Sci Transl Med. 2023. PMID: 37224225 Free PMC article.
A Molecular Urine Assay to Detect Recurrences During Surveillance of High-Risk Non-Muscle Invasive Bladder Cancer.
de Jong JJ, de Jong FC, van der Made ACJ, van Casteren NJ, Roshani H, Oomens EHGM, Pelger RCM, Steyerberg EW, Boormans JL, Bangma CH, Zuiverloon TCM, Zwarthoff EC. de Jong JJ, et al. Among authors: boormans jl. Bladder Cancer. 2024 Oct 23;10(3):233-242. doi: 10.3233/BLC-240017. eCollection 2024. Bladder Cancer. 2024. PMID: 39493819 Free PMC article.
No evidence of FGFR3 mutations in prostate cancer.
Zuiverloon TC, Boormans JL, Trapman J, van Leenders GJ, Zwarthoff EC. Zuiverloon TC, et al. Among authors: boormans jl. Prostate. 2011 May;71(6):637-41. doi: 10.1002/pros.21279. Epub 2010 Oct 18. Prostate. 2011. PMID: 20957671
144 results